Showing 1 - 5 results of 5 for search 'Milene T. Saavedra', query time: 0.03s Refine Results
  1. 1
    Corticosteroid use and increased CXCR2 levels on leukocytes are associated with lumacaftor/ivacaftor discontinuation in cystic fibrosis patients homozygous for the F508del CFTR mutation.

    Corticosteroid use and increased CXCR2 levels on leukocytes are associated with lumacaftor/ivacaftor discontinuation in cystic fibrosis patients homozygous for the F508del CFTR mut... by Kerstin Pohl, David P Nichols, Jennifer L Taylor-Cousar, Milene T Saavedra, Matthew J Strand, Jerry A Nick, Preston E Bratcher

    Published 2018-01-01
    Get full text
    Article
  2. 2
    Specificity of Immunoglobulin Response to Nontuberculous Mycobacteria Infection in People with Cystic Fibrosis

    Specificity of Immunoglobulin Response to Nontuberculous Mycobacteria Infection in People with Cystic Fibrosis by Kenneth C. Malcolm, Emily A. Wheeler, Kara Calhoun, Patricia M. Lenhart-Pendergrass, Noel Rysavy, Katie R. Poch, Silvia M. Caceres, Milene T. Saavedra, Jerry A. Nick

    Published 2022-08-01
    Get full text
    Article
  3. 3
    Neutrophil extracellular trap (NET)-mediated killing of Pseudomonas aeruginosa: evidence of acquired resistance within the CF airway, independent of CFTR.

    Neutrophil extracellular trap (NET)-mediated killing of Pseudomonas aeruginosa: evidence of acquired resistance within the CF airway, independent of CFTR. by Robert L Young, Kenneth C Malcolm, Jennifer E Kret, Silvia M Caceres, Katie R Poch, David P Nichols, Jennifer L Taylor-Cousar, Milene T Saavedra, Scott H Randell, Michael L Vasil, Jane L Burns, Samuel M Moskowitz, Jerry A Nick

    Published 2011-01-01
    Get full text
    Article
  4. 4
    Blood mRNA biomarkers distinguish variable systemic and sputum inflammation at treatment initiation of inhaled antibiotics in cystic fibrosis: A prospective non-randomized trial.

    Blood mRNA biomarkers distinguish variable systemic and sputum inflammation at treatment initiation of inhaled antibiotics in cystic fibrosis: A prospective non-randomized trial. by Silvia M Caceres, Linda A Sanders, Noel M Rysavy, Katie R Poch, Caroline R Jones, Kyle Pickard, Tasha E Fingerlin, Roland A Marcus, Kenneth C Malcolm, Jennifer L Taylor-Cousar, David P Nichols, Jerry A Nick, Matthew Strand, Milene T Saavedra

    Published 2022-01-01
    Get full text
    Article
  5. 5
    Extremes of Interferon-Stimulated Gene Expression Associate with Worse Outcomes in the Acute Respiratory Distress Syndrome.

    Extremes of Interferon-Stimulated Gene Expression Associate with Worse Outcomes in the Acute Respiratory Distress Syndrome. by Jerry A Nick, Silvia M Caceres, Jennifer E Kret, Katie R Poch, Matthew Strand, Anna V Faino, David P Nichols, Milene T Saavedra, Jennifer L Taylor-Cousar, Mark W Geraci, Ellen L Burnham, Michael B Fessler, Benjamin T Suratt, Edward Abraham, Marc Moss, Kenneth C Malcolm

    Published 2016-01-01
    Get full text
    Article

Search Tools: